A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma

Background: The aim of our study was to develop a nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with gastric signet ring cell carcinoma (GSRC). Methods: GSRC patients from 2004 to 2015 were collected from the Surveillance, Epidemiology, and End Result...

Full description

Bibliographic Details
Main Authors: Qinping Guo MD, Yinquan Wang MD, Jie An MD, Siben Wang MD, Xiushan Dong MD, Haoliang Zhao PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-06-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211027912
id doaj-309e183eeb0d482eb323898976e6f689
record_format Article
spelling doaj-309e183eeb0d482eb323898976e6f6892021-06-30T22:34:59ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382021-06-012010.1177/15330338211027912A Prognostic Model for Patients With Gastric Signet Ring Cell CarcinomaQinping Guo MD0Yinquan Wang MD1Jie An MD2Siben Wang MD3Xiushan Dong MD4Haoliang Zhao PhD5 Department of General Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi Province, China Department of General Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi Province, China Department of General Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi Province, China Department of Thoracic Surgery, Huainan First People’s Hospital, Huainan, Anhui Province, China Department of General Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi Province, China Department of General Surgery, Shanxi Bethune Hospital, Taiyuan, Shanxi Province, ChinaBackground: The aim of our study was to develop a nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with gastric signet ring cell carcinoma (GSRC). Methods: GSRC patients from 2004 to 2015 were collected from the Surveillance, Epidemiology, and End Results (SEER) database and randomly assigned to the training and validation sets. Multivariate Cox regression analyses screened for OS and CSS independent risk factors and nomograms were constructed. Results: A total of 7,149 eligible GSRC patients were identified, including 4,766 in the training set and 2,383 in the validation set. Multivariate Cox regression analysis showed that gender, marital status, race, AJCC stage, TNM stage, surgery and chemotherapy were independent risk factors for both OS and CSS. Based on the results of the multivariate Cox regression analysis, prognostic nomograms were constructed for OS and CSS. In the training set, the C-index was 0.754 (95% CI = 0.746-0.762) for the OS nomogram and 0.762 (95% CI: 0.753-0.771) for the CSS nomogram. In the internal validation, the C-index for the OS nomogram was 0.758 (95% CI: 0.746-0.770), while the C-index for the CSS nomogram was 0.762 (95% CI: 0.749-0.775). Compared with TNM stage and SEER stage, the nomogram had better predictive ability. In addition, the calibration curves also showed good consistency between the predicted and actual 3-year and 5-year OS and CSS. Conclusion: The nomogram can effectively predict OS and CSS in patients with GSRC, which may help clinicians to personalize prognostic assessments and clinical decisions.https://doi.org/10.1177/15330338211027912
collection DOAJ
language English
format Article
sources DOAJ
author Qinping Guo MD
Yinquan Wang MD
Jie An MD
Siben Wang MD
Xiushan Dong MD
Haoliang Zhao PhD
spellingShingle Qinping Guo MD
Yinquan Wang MD
Jie An MD
Siben Wang MD
Xiushan Dong MD
Haoliang Zhao PhD
A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
Technology in Cancer Research & Treatment
author_facet Qinping Guo MD
Yinquan Wang MD
Jie An MD
Siben Wang MD
Xiushan Dong MD
Haoliang Zhao PhD
author_sort Qinping Guo MD
title A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
title_short A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
title_full A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
title_fullStr A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
title_full_unstemmed A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma
title_sort prognostic model for patients with gastric signet ring cell carcinoma
publisher SAGE Publishing
series Technology in Cancer Research & Treatment
issn 1533-0338
publishDate 2021-06-01
description Background: The aim of our study was to develop a nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with gastric signet ring cell carcinoma (GSRC). Methods: GSRC patients from 2004 to 2015 were collected from the Surveillance, Epidemiology, and End Results (SEER) database and randomly assigned to the training and validation sets. Multivariate Cox regression analyses screened for OS and CSS independent risk factors and nomograms were constructed. Results: A total of 7,149 eligible GSRC patients were identified, including 4,766 in the training set and 2,383 in the validation set. Multivariate Cox regression analysis showed that gender, marital status, race, AJCC stage, TNM stage, surgery and chemotherapy were independent risk factors for both OS and CSS. Based on the results of the multivariate Cox regression analysis, prognostic nomograms were constructed for OS and CSS. In the training set, the C-index was 0.754 (95% CI = 0.746-0.762) for the OS nomogram and 0.762 (95% CI: 0.753-0.771) for the CSS nomogram. In the internal validation, the C-index for the OS nomogram was 0.758 (95% CI: 0.746-0.770), while the C-index for the CSS nomogram was 0.762 (95% CI: 0.749-0.775). Compared with TNM stage and SEER stage, the nomogram had better predictive ability. In addition, the calibration curves also showed good consistency between the predicted and actual 3-year and 5-year OS and CSS. Conclusion: The nomogram can effectively predict OS and CSS in patients with GSRC, which may help clinicians to personalize prognostic assessments and clinical decisions.
url https://doi.org/10.1177/15330338211027912
work_keys_str_mv AT qinpingguomd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT yinquanwangmd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT jieanmd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT sibenwangmd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT xiushandongmd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT haoliangzhaophd aprognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT qinpingguomd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT yinquanwangmd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT jieanmd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT sibenwangmd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT xiushandongmd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
AT haoliangzhaophd prognosticmodelforpatientswithgastricsignetringcellcarcinoma
_version_ 1721352482572992512